Giancarlo Stanton prefers the two-run shot over the two-shot run, but the New York Yankees’ designated hitter required a second round of platelet-rich plasma injections to address chronic elbow pain.Team president Brian Cashman said Thursday the latest development puts New York into “a little bit of the unknown” with the 35-year-old slugger who will begin the season on the injured list.Stanton left spring training within days of his arrival to visit team doctors in New York, where his first round of PRP injections took place. But the pain was not greatly reduced, and Cashman said the Yankees are planning to be “conservative” with the right-handed power hitter. The team didn’t believe the issue warranted offseason attention because Stanton had not complained of pain or discomfort.Stanton said three weeks before spring training began, the pain in his elbows returned.”The complaints didn’t come until obviously right before camp,” Cashman said Thursday. “Now we’re dealing with it. Give it the time it needs. Hoping to get him back at some point, but in the near-term, that won’t be the case.”Cashman said the uncertainty means surgery can’t be ruled out. He said it would be a “last resort” as Stanton said he’s prepared to play in pain again.”Obviously the PRP injections are designed to help the healing process,” Cashman said. “You hope that’s the case. A, you have to let it all take and B, you have to let it all play out. And hopefully you get a positive resolution.”The MVP of the 2024 American League Championship Series, Stanton was bothered by deep soreness in his elbows for much of last season. He still hit 27 home runs and drove in 72 runs over 114 games in the regular season.